2
Clinical Trials associated with Universal CAR-γδT Cell(Hebei Senlangbio Biotechnology) / Unknown statusNot Applicable Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Refractory and Relapsed AML Patients
To evaluate the safety of general-purpose CAR-γδT cells in patients with refractory post-transplant relapsed AML.
/ Unknown statusNot Applicable Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation
This is an open single-arm clinical study aimed at evaluating the efficacy and safety of universal γδT cell injection in the treatment of patients with relapsed AML after transplantation
100 Clinical Results associated with Universal CAR-γδT Cell(Hebei Senlangbio Biotechnology)
100 Translational Medicine associated with Universal CAR-γδT Cell(Hebei Senlangbio Biotechnology)
100 Patents (Medical) associated with Universal CAR-γδT Cell(Hebei Senlangbio Biotechnology)
100 Deals associated with Universal CAR-γδT Cell(Hebei Senlangbio Biotechnology)